Articles From: Iowa First Bancshares Corp. Reports Second Quarter Financial Results and Dividend Payment to Ipsen Appoints Cynthia Schwalm as President and CEO of Ipsen North America


Iowa First Bancshares Corp.
Sign-up for Iowa First Bancshares Corp. Reports Second Quarter Financial Results and Dividend Payment investment picks
2014/7/15
The State of Iowa has signed a new long-term contract with Iowa Interactive, LLC to provide eGovernment services through the state’s official Web portal ( http://www.iowa.gov ). The contract includes an initial two-year term with renewal options that the state can exercise taking the contract through June 2020.
Sign-up for Iowa Interactive LLC Selected to Continue Providing eGovernment Services for the State of Iowa investment picks
http://media.marketwire.com/attachments/201311/200249_iPass_logo_color.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136360&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Announces Presentation at the Oppenheimer 17th Annual Technology, Internet & Communications Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136874&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Reports Sequential Revenue Growth in the Second Quarter 2014 investment picks
http://media.marketwire.com/attachments/201310/193404_iPass_logo_color.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1128007&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Sells Unity Business Unit to Tolt Solutions for $28.2 Million investment picks
http://media.marketwire.com/attachments/201205/45279_iPasslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142963&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass to Explore Strategic Alternatives investment picks
http://media.marketwire.com/attachments/201310/193404_iPass_logo_color.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133832&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass to Report Second Quarter 2014 Financial Results on August 11 investment picks
IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, announced that it has appointed Jeffrey Winter to the newly created position of Senior Vice President of Sales and Marketing.
Sign-up for IPC Hires New Senior Vice President of Sales and Marketing investment picks
NORTH HOLLYWOOD, Calif., June 17, 2014 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM) today issued the following statement regarding the complaint filed on June 16, 2014 by the U.S. Department of Justice: The complaint is in connection with a civil investigative demand (CID) issued by the Department of Justice (DOJ) in June 2010 concerning claims for reimbursement that IPC submitted primarily to Medicare and Medicaid.
Sign-up for IPC Issues Statement Regarding Department of Justice Complaint investment picks
NORTH HOLLYWOOD, Calif., Aug.
Sign-up for IPC The Hospitalist Company Acquires Connecticut Geriatric Practice investment picks
NORTH HOLLYWOOD, Calif., Aug.
Sign-up for IPC The Hospitalist Company Acquires Two Florida Practices investment picks
NORTH HOLLYWOOD, Calif., Sept.
Sign-up for IPC The Hospitalist Company Expands Florida Presence With ECHIS Acquisition investment picks
NORTH HOLLYWOOD, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM) , a leading national hospitalist physician group practice, today announced financial results for the second quarter ended June 30, 2014.
Sign-up for IPC The Hospitalist Company Reports Second Quarter 2014 Financial Results investment picks
NORTH HOLLYWOOD, Calif., Sept.
Sign-up for IPC The Hospitalist Company to Participate in Credit Suisse Small & Mid Cap Conference investment picks
NORTH HOLLYWOOD, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM) , a leading national hospitalist physician group practice, will report its financial results for the second quarter ended June 30, 2014 on Wednesday, July 23, 2014, after the market close.
Sign-up for IPC The Hospitalist Company to Report Second-Quarter 2014 Financial Results investment picks
NORTH HOLLYWOOD, Calif., Aug.
Sign-up for IPC The Hospitalist Company, Inc. to Participate in Avondale Partners Healthcare 1-1 Conference investment picks
IPG Photonics Corporation (NASDAQ: IPGP) announced today that in conjunction with its scheduled quarterly financial results news release, Chairman and Chief Executive Officer Dr.
Sign-up for IPG Photonics Corporation to Announce Second-Quarter 2014 Financial Results on July 29 investment picks
IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the second quarter ended June 30, 2014.
Sign-up for IPG Photonics Reports 14% Revenue Growth for Second Quarter 2014 investment picks
IPG Photonics Corporation (NASDAQ: IPGP) today announced that its Chief Financial Officer, Tim Mammen, will be presenting at Needham’s 3 rd Annual Advanced Industrial Technologies Conference on Thursday, August 7, 2014 at 2:30 p.m. ET.
Sign-up for IPG Photonics to Present at Needham 3rd Annual Advanced Industrial Technologies Conference investment picks
Alaska Communications (NASDAQ:ALSK) today announced it will offer iPhone 6 and iPhone 6 Plus, the biggest advancements in iPhone history, beginning Friday, Sept.
Sign-up for iPhone 6 and 6 Plus Arrive at Alaska Communications Sept. 26 investment picks
2014/9/4
By Rex Crum, MarketWatch SAN FRANCISCO (MarketWatch) -- What is probably the most-anticipated business event of the fall, if not the year, is about to take place.
Sign-up for iPhone 6 set to kick off new season for Apple investment picks
By Michael Kitchen, MarketWatch LOS ANGELES (MarketWatch) -- Regardless of whether a new iPhone will be a game-changer for Apple Inc. (AAPL) , the device has the potential to juice the second-largest economy on Earth, or so say economists at Bank of America-Merrill Lynch.
Sign-up for iPhone may single-handedly move China's economy investment picks
2014/9/2
Last week's review of corporations and law firms NEW YORK , Sept.
Sign-up for IPOs and Transactions: August 25 - 29 investment picks
2014/9/8
Last week's review of corporations and law firms NEW YORK , Sept.
Sign-up for IPOs and Transactions: September 2 - 5 investment picks
2014/9/15
Last week's review of corporations and law firms NEW YORK , Sept.
Sign-up for IPOs and Transactions: September 8 - 12 investment picks
2014/7/11
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, and Galderma, a global healthcare company focused on dermatology and skin health, today announced that they have significantly expanded the scope of their neurotoxin partnership.
Sign-up for Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1 investment picks
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline ® Depot ® 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options.
Sign-up for Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe investment picks
Ipsen N.A. , an affiliate of Ipsen (Euronext:IPN; ADR:IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline ® Depot ® 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options.
Sign-up for Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NETs1 in the US with Priority Review investment picks
2014/8/26
Ipsen N.A. (Euronext: IPN; ADR: IPSEY) today announced that a new supply of Increlex ® will be available starting in September 2014.
Sign-up for Ipsen Announces Second Resupply of Increlex® (mecasermin [rDNA origin] Injection) in the U.S. in 2014 investment picks
2014/8/20
Ipsen (Euronext:IPN; ADR:IPSEY) today announced that Cynthia Schwalm has been named President and CEO of Ipsen N.A ., responsible for all commercial and medical affairs operations throughout the region.
Sign-up for Ipsen Appoints Cynthia Schwalm as President and CEO of Ipsen North America investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Iowa First Bancshares Corp. Reports Second Quarter Financial Results and Dividend Payment to Ipsen Appoints Cynthia Schwalm as President and CEO of Ipsen North America
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices